Analisador de Hematologia Cbc Reagentes para Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind

N ° de Modelo.
JXK-203
Especificação
975ml*4
Marca Registrada
Xinke
Origem
China
Código HS
3822009000
Capacidade de Produção
5000cartons/Year
Preço de referência
$ 0.81 - 0.90

Descrição de Produto

descrição do Produto

 

Analisador de hematologia reagentes para Mindray/Coulter/Sysmex/Nihon Kohden MEK/ABX/Abbott/SWELAB/Medonic/TEK/Prokan/Maxcom/Urit
       

Mindray---BC5150 BC5000, BC6800, BC5500, BC5200, BC5100,BC5180, BC5300,BC5380, BC2000,BC2200,BC2100, BC2300, BC1800,BC2600,BC2800, BC3000, BC3200,BC20S

Sysmex---XE-2001i , XE-5000i ,XT1800i, XT-2000i, XT-4000i , XS-500i,XS-800i, XS-1000i , KX-21, POCH100i ,K1000,K4500

 

A Abbott CELL-DYN---CD3000, CD3500,CD3700,CD3200 Ruby, CD1400EX, CD1600,CD1700,CD1800

 

ABX---Pentra60, Pentra80, Pentra120 , Micros60, micro-PCR, OT18, ADVIA60, a HORIBA-LC550

 

Coulter---AC.T 5 Diff,  MAXM, STKS, HMX, Gen.n. S, LH500/750 , T series , JT series , ONYX series , Diff II, acto.dif

 

NIHON KOHDEN---MEK7222K, MEK8222K, MEK6108K, MEK6318K, MEK8118K, MEK6410P

 

Swelab ac---AC900, AC920, AC970

Medonic---CA620 CA530 CA610 CA570

Landwind lw d3600

Mítico Orphee 18

 

Detalhes de imagens

Cbc Hematology Analyzer Reagents for Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind
 
 
Certificados
Cbc Hematology Analyzer Reagents for Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind

Parte do nosso laboratório
Cbc Hematology Analyzer Reagents for Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind
Embalagem e envio
Cbc Hematology Analyzer Reagents for Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind

 
Cbc Hematology Analyzer Reagents for Mindray/Coulter/Sysmex/Nihon Kohden MEK/Abx/Abbott/Swelab/Medonic/Prokan/Maxcom/Urit/Landwind
Informações de contato

 

SUPERAUTO.CAT, 2023